Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
Open Access
- 11 July 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 30 (21), 2575-2583
- https://doi.org/10.1093/eurheartj/ehp279
Abstract
Red blood cell transfusion is associated with increased mortality among patients with acute coronary syndromes, but little is known about the consequences of transfusion in a contemporary setting of ST-segment elevation myocardial infarction. We describe the association between transfusion and 90-day mortality among patients with acute myocardial infarction treated with primary percutaneous coronary intervention. Analyses were performed on 5532 patients with ST-elevation myocardial infarction from the Assessment of Pexelizumab in Acute Myocardial Infarction trial. The primary objective of this analysis was to ascertain the relation between red blood cell transfusion and 90-day mortality in patients with recent myocardial infarction. We initially determined the baseline and in-hospital predictors of transfusion (multivariable logistic regressions) and subsequently assessed the association between transfusion and mortality using a series of Cox proportional hazards regression combined to a landmark analyses. A total of 213 patients (3.9%) received a transfusion. Transfusion remained significantly associated with mortality [hazards ratio = 2.16 (1.20–3.88)], despite adjustment for baseline characteristics, in-hospital co-interventions, and for propensity of receiving a transfusion. Among patients who survived to hospital discharge, however, the hazard of death was not different in patients treated with transfusion. Transfusion is associated with 90-day mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. Although transfusion may be causally related to mortality, it is likely that at least part of the association is due to confounding. This association illustrates the complex relationship between transfusion, bleeding, and mortality and underscores the need for further research to understand the relationship between transfusion and clinical outcomes.Keywords
This publication has 31 references indexed in Scilit:
- Periprocedural Bleeding and 1-Year Outcome After Percutaneous Coronary Interventions: Appropriateness of Including Bleeding as a Component of a Quadruple End PointJournal of the American College of Cardiology, 2008
- Impact of Preoperative Anemia on Outcome in Patients Undergoing Coronary Artery Bypass Graft SurgeryCirculation, 2007
- Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary InterventionJama-Journal Of The American Medical Association, 2007
- Adverse Impact of Bleeding on Prognosis in Patients With Acute Coronary SyndromesCirculation, 2006
- The Implications of Blood Transfusions for Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE National Quality Improvement InitiativeJournal of the American College of Cardiology, 2005
- Association of Hemoglobin Levels With Clinical Outcomes in Acute Coronary SyndromesCirculation, 2005
- Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary interventionAmerican Heart Journal, 2005
- Relationship of Blood Transfusion and Clinical Outcomes in Patients With Acute Coronary SyndromesPublished by American Medical Association (AMA) ,2004
- Blood transfusion in elderly patients with acute myocardial infarction.New England Journal of Medicine, 2001
- A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical CareNew England Journal of Medicine, 1999